170 related articles for article (PubMed ID: 38545760)
21. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
Fu J; Fang F; Xie L; Chen H; He F; Wu T; Hu L; Lawrie TA
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD007289. PubMed ID: 23076934
[TBL] [Abstract][Full Text] [Related]
22. The management and outcome of women with post-hydatidiform mole 'low-risk' gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(-1).
McGrath S; Short D; Harvey R; Schmid P; Savage PM; Seckl MJ
Br J Cancer; 2010 Mar; 102(5):810-4. PubMed ID: 20160727
[TBL] [Abstract][Full Text] [Related]
23. Clinical Features of Gestational Trophoblastic Disease in Aged Women in South Vietnam.
Nguyen BQ; Vo TM; Phan VTT; Nguyen C; Vu H; Vo B
Yonsei Med J; 2023 Apr; 64(4):284-290. PubMed ID: 36996900
[TBL] [Abstract][Full Text] [Related]
24. The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study.
Yamamoto E; Trinh TD; Sekiya Y; Tamakoshi K; Nguyen XP; Nishino K; Niimi K; Kotani T; Kajiyama H; Shibata K; Le QT; Kikkawa F
Nagoya J Med Sci; 2020 May; 82(2):183-191. PubMed ID: 32581399
[TBL] [Abstract][Full Text] [Related]
25. Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center.
Gockley AA; Joseph NT; Melamed A; Sun SY; Goodwin B; Bernstein M; Goldstein DP; Berkowitz RS; Horowitz NS
Am J Obstet Gynecol; 2016 Sep; 215(3):334.e1-6. PubMed ID: 27130239
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].
Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430
[TBL] [Abstract][Full Text] [Related]
27. Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia.
Worley MJ; Joseph NT; Berkowitz RS; Goldstein DP
Int J Gynecol Cancer; 2014 Jun; 24(5):941-5. PubMed ID: 24819660
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience.
Maestá I; Nitecki R; Horowitz NS; Goldstein DP; de Freitas Segalla Moreira M; Elias KM; Berkowitz RS
Gynecol Oncol; 2018 Jan; 148(1):161-167. PubMed ID: 29092742
[TBL] [Abstract][Full Text] [Related]
29. Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study.
Braga A; Paiva G; Ghorani E; Freitas F; Velarde LGC; Kaur B; Unsworth N; Lozano-Kuehne J; Dos Santos Esteves APV; Rezende Filho J; Amim J; Aguiar X; Sarwar N; Elias KM; Horowitz NS; Berkowitz RS; Seckl MJ
Lancet Oncol; 2021 Aug; 22(8):1188-1198. PubMed ID: 34181884
[TBL] [Abstract][Full Text] [Related]
30. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
31. Gestational trophoblastic neoplasia: a meta-analysis evaluating reproductive and obstetrical outcomes after administration of chemotherapy.
Tranoulis A; Georgiou D; Sayasneh A; Tidy J
Int J Gynecol Cancer; 2019 Jul; 29(6):1021-1031. PubMed ID: 31253638
[TBL] [Abstract][Full Text] [Related]
32. Early prediction of post-molar gestational trophoblastic neoplasia and resistance to methotrexate, based on a single serum human chorionic gonadotropin measurement.
Hoeijmakers YM; Eysbouts YK; Massuger LFAG; Dandis R; Inthout J; van Trommel NE; Ottevanger PB; Thomas CMG; Sweep FCGJ
Gynecol Oncol; 2021 Dec; 163(3):531-537. PubMed ID: 34602288
[TBL] [Abstract][Full Text] [Related]
33. First-line hysterectomy for women with low-risk non-metastatic gestational trophoblastic neoplasia no longer wishing to conceive.
Bolze PA; Mathe M; Hajri T; You B; Dabi Y; Schott AM; Patrier S; Massardier J; Golfier F
Gynecol Oncol; 2018 Aug; 150(2):282-287. PubMed ID: 29887485
[TBL] [Abstract][Full Text] [Related]
34. Epidemiologic study on gestational trophoblastic diseases in Japan.
Yamamoto E; Nishino K; Niimi K; Ino K
J Gynecol Oncol; 2022 Nov; 33(6):e72. PubMed ID: 36047375
[TBL] [Abstract][Full Text] [Related]
35. Reproductive outcomes after hydatiform mole and gestational trophoblastic neoplasia.
Gadducci A; Lanfredini N; Cosio S
Gynecol Endocrinol; 2015; 31(9):673-8. PubMed ID: 26288335
[TBL] [Abstract][Full Text] [Related]
36. Second curettage versus conventional chemotherapy in avoiding unnecessary chemotherapy and reducing the number of chemotherapy courses for patients with gestational trophoblastic neoplasia: A systematic review and meta-analysis.
Zhao P; Yu Y; Du M; Xu J; Lu W
Int J Gynaecol Obstet; 2024 Apr; 165(1):34-42. PubMed ID: 37753799
[TBL] [Abstract][Full Text] [Related]
37. State-of-the-Art Workup and Initial Management of Newly Diagnosed Molar Pregnancy and Postmolar Gestational Trophoblastic Neoplasia.
Elias KM; Berkowitz RS; Horowitz NS
J Natl Compr Canc Netw; 2019 Nov; 17(11):1396-1401. PubMed ID: 31693988
[TBL] [Abstract][Full Text] [Related]
38. Surveillance for gestational trophoblastic neoplasia following molar pregnancy: a cost-effectiveness analysis.
Albright BB; Myers ER; Moss HA; Ko EM; Sonalkar S; Havrilesky LJ
Am J Obstet Gynecol; 2021 Nov; 225(5):513.e1-513.e19. PubMed ID: 34058170
[TBL] [Abstract][Full Text] [Related]
39. Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0-4): study protocol for a prospective, multicentre, randomized trial.
Jiang F; Mao MY; Xiang Y; Lu X; Guan CL; Jiao LZ; Wan XR; Feng FZ; Ren T; Yang JJ; Zhao J
BMC Cancer; 2023 Aug; 23(1):784. PubMed ID: 37612621
[TBL] [Abstract][Full Text] [Related]
40. Timing of Referral to the New England Trophoblastic Disease Center: Does Referral with Molar Pregnancy Versus Postmolar Gestational Trophoblastic Neoplasia Affect Outcomes?
Diver EJ; Horowitz NS; Goldstein DP; Bernstein M; Berkowitz RS; Growdon WB
J Reprod Med; 2016; 61(5-6):187-91. PubMed ID: 27424356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]